开发和验证igf -1修改的Child-Pugh评分对肝细胞癌患者进行风险分层

A. Kaseb, Lianchun Xiao, R. Naguib, Wafaa El-Shikh, Manal M. Hassan, H. Hassabo, Jeong‐Hoon Lee, Jung‐Hwan Yoon, Hyo‐suk Lee, Y. Chae, J. Abbruzzese, Jeffrey S. Morris
{"title":"开发和验证igf -1修改的Child-Pugh评分对肝细胞癌患者进行风险分层","authors":"A. Kaseb, Lianchun Xiao, R. Naguib, Wafaa El-Shikh, Manal M. Hassan, H. Hassabo, Jeong‐Hoon Lee, Jung‐Hwan Yoon, Hyo‐suk Lee, Y. Chae, J. Abbruzzese, Jeffrey S. Morris","doi":"10.4103/2356-8062.159986","DOIUrl":null,"url":null,"abstract":"Background The Child-Turcotte-Pugh (CTP) score inaccurately predicts survival in patients with chronic liver disease, including hepatocellular carcinoma (HCC), yet remains the standard tool for assessing hepatic reserve and guiding therapeutic decisions. CTP scoring relies on objective laboratory values for albumin, bilirubin, and prothrombin time and subjective clinical grading of hepatic encephalopathy and ascites. As liver production of insulin-like growth factor-1 (IGF-1) is significantly reduced in patients with cirrhosis, we hypothesized that IGF-1 could be a valid surrogate for hepatic reserve to replace the subjective parameters in CTP scores. Materials and methods We prospectively enrolled patients and collected data and retrospectively tested plasma IGF-1 levels in four independent cohorts: two HCC cohorts from the USA [n = 310 (training set) and n = 99 (validation set 1)]; one HCC cohort from Korea [n = 188 (validation set 2)]; and one cirrhosis cohort from Egypt [n = 71 (validation set 3)]. Recursive partitioning identified within the training set three optimal IGF-1 ranges that correlated with survival: >50 ng/ml = 1 point; 26-50 ng/ml = 2 points; and <26 ng/ml = 3 points. We modified the CTP score by replacing ascites and encephalopathy grading with IGF-1 values, subjected both the resulting IGF score and the CTP score to log-rank analysis, and quantified the prognostic values with C-statistics to compare the scores′ performance in all cohorts. Results The IGF score was significantly more accurate in predicting survival and improved the stratification of all CTP classes in the training and validation cohorts. Conclusion The new IGF score is simple and blood-based, and validated well on multiple independent HCC cohorts. It could identify a subpopulation of patients who may benefit from active therapy because of their preserved hepatic reserve, as distinct from patients for whom therapy can be deferred or avoided.","PeriodicalId":260758,"journal":{"name":"Egyptian Journal of Obesity, Diabetes and Endocrinology","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and validation of an IGF-1-modified Child-Pugh score to risk-stratify hepatocellular carcinoma patients\",\"authors\":\"A. Kaseb, Lianchun Xiao, R. Naguib, Wafaa El-Shikh, Manal M. Hassan, H. Hassabo, Jeong‐Hoon Lee, Jung‐Hwan Yoon, Hyo‐suk Lee, Y. Chae, J. Abbruzzese, Jeffrey S. Morris\",\"doi\":\"10.4103/2356-8062.159986\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background The Child-Turcotte-Pugh (CTP) score inaccurately predicts survival in patients with chronic liver disease, including hepatocellular carcinoma (HCC), yet remains the standard tool for assessing hepatic reserve and guiding therapeutic decisions. CTP scoring relies on objective laboratory values for albumin, bilirubin, and prothrombin time and subjective clinical grading of hepatic encephalopathy and ascites. As liver production of insulin-like growth factor-1 (IGF-1) is significantly reduced in patients with cirrhosis, we hypothesized that IGF-1 could be a valid surrogate for hepatic reserve to replace the subjective parameters in CTP scores. Materials and methods We prospectively enrolled patients and collected data and retrospectively tested plasma IGF-1 levels in four independent cohorts: two HCC cohorts from the USA [n = 310 (training set) and n = 99 (validation set 1)]; one HCC cohort from Korea [n = 188 (validation set 2)]; and one cirrhosis cohort from Egypt [n = 71 (validation set 3)]. Recursive partitioning identified within the training set three optimal IGF-1 ranges that correlated with survival: >50 ng/ml = 1 point; 26-50 ng/ml = 2 points; and <26 ng/ml = 3 points. We modified the CTP score by replacing ascites and encephalopathy grading with IGF-1 values, subjected both the resulting IGF score and the CTP score to log-rank analysis, and quantified the prognostic values with C-statistics to compare the scores′ performance in all cohorts. Results The IGF score was significantly more accurate in predicting survival and improved the stratification of all CTP classes in the training and validation cohorts. Conclusion The new IGF score is simple and blood-based, and validated well on multiple independent HCC cohorts. It could identify a subpopulation of patients who may benefit from active therapy because of their preserved hepatic reserve, as distinct from patients for whom therapy can be deferred or avoided.\",\"PeriodicalId\":260758,\"journal\":{\"name\":\"Egyptian Journal of Obesity, Diabetes and Endocrinology\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Journal of Obesity, Diabetes and Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/2356-8062.159986\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Obesity, Diabetes and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2356-8062.159986","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

child - turcote - pugh (CTP)评分不能准确预测包括肝细胞癌(HCC)在内的慢性肝病患者的生存,但仍是评估肝脏储备和指导治疗决策的标准工具。CTP评分依赖于白蛋白、胆红素和凝血酶原时间的客观实验室值以及肝性脑病和腹水的主观临床分级。由于肝硬化患者肝脏产生的胰岛素样生长因子-1 (IGF-1)显著减少,我们假设IGF-1可以作为肝储备的有效替代品,取代CTP评分中的主观参数。我们在四个独立的队列中前瞻性地招募患者,收集数据并回顾性地检测血浆IGF-1水平:两个来自美国的HCC队列[n = 310(训练集)和n = 99(验证集1)];一个来自韩国的HCC队列[n = 188(验证集2)];一个来自埃及的肝硬化队列[n = 71(验证集3)]。递归划分在训练集中确定了与生存相关的三个最佳IGF-1范围:>50 ng/ml = 1点;26-50 ng/ml = 2分;<26 ng/ml = 3分。我们修改了CTP评分,用IGF-1值代替腹水和脑病分级,对所得的IGF评分和CTP评分进行log-rank分析,并用C-statistics量化预后值,比较所有队列中评分的表现。结果在训练和验证队列中,IGF评分在预测生存方面明显更准确,并改善了所有CTP类别的分层。结论新的IGF评分方法简单,基于血液,在多个独立的HCC队列中得到了很好的验证。它可以识别出一个亚群患者,他们可能受益于积极治疗,因为他们保留了肝脏储备,而不是那些可以推迟或避免治疗的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Development and validation of an IGF-1-modified Child-Pugh score to risk-stratify hepatocellular carcinoma patients
Background The Child-Turcotte-Pugh (CTP) score inaccurately predicts survival in patients with chronic liver disease, including hepatocellular carcinoma (HCC), yet remains the standard tool for assessing hepatic reserve and guiding therapeutic decisions. CTP scoring relies on objective laboratory values for albumin, bilirubin, and prothrombin time and subjective clinical grading of hepatic encephalopathy and ascites. As liver production of insulin-like growth factor-1 (IGF-1) is significantly reduced in patients with cirrhosis, we hypothesized that IGF-1 could be a valid surrogate for hepatic reserve to replace the subjective parameters in CTP scores. Materials and methods We prospectively enrolled patients and collected data and retrospectively tested plasma IGF-1 levels in four independent cohorts: two HCC cohorts from the USA [n = 310 (training set) and n = 99 (validation set 1)]; one HCC cohort from Korea [n = 188 (validation set 2)]; and one cirrhosis cohort from Egypt [n = 71 (validation set 3)]. Recursive partitioning identified within the training set three optimal IGF-1 ranges that correlated with survival: >50 ng/ml = 1 point; 26-50 ng/ml = 2 points; and <26 ng/ml = 3 points. We modified the CTP score by replacing ascites and encephalopathy grading with IGF-1 values, subjected both the resulting IGF score and the CTP score to log-rank analysis, and quantified the prognostic values with C-statistics to compare the scores′ performance in all cohorts. Results The IGF score was significantly more accurate in predicting survival and improved the stratification of all CTP classes in the training and validation cohorts. Conclusion The new IGF score is simple and blood-based, and validated well on multiple independent HCC cohorts. It could identify a subpopulation of patients who may benefit from active therapy because of their preserved hepatic reserve, as distinct from patients for whom therapy can be deferred or avoided.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Immunostimulatory effect of ketogenic diet in cyclophosphamide-induced immunosuppression in adult albino rats Prevalence of vitamin D deficiency and persistent hyperparathyroidism in an Egyptian cohort of renal transplant recipients: a cross-sectional study Relationship of neck circumference to some cardiometabolic risk parameters: a cross-sectional study among obese adult Egyptians Study of the possible relations between vitamin D, telomere length, and high-sensitivity C-reactive protein in older people Urinary levels of podocalyxin as a marker for podocytopathy in patients with metabolic syndrome having high body mass index: a diagnostic test accuracy study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1